REDWOOD CITY, Calif.--(BUSINESS WIRE)--May 2, 2017--
Dextera Surgical Inc. (Nasdaq: DXTR), a company commercializing and
developing the MicroCutter 5/80™ stapler based on its proprietary
‘‘staple-on-a-strip’’ technology intended for use by thoracic,
pediatric, bariatric, colorectal and general surgeons, today announced
that it will release financial results for its fiscal 2017 third quarter
ended March 31, 2017 on Thursday, May 4, 2017, after the markets close.
Dextera Surgical’s management will hold a conference call at 4:30 p.m.
Eastern Time to discuss the financial results and provide an update on
the company’s business.
Conference Call Details
To access the live conference call on May 4, 2017, at 4:30 p.m. Eastern
Time via phone, please dial 844-419-1785 from the United States and
Canada or 216-562-0472. The conference ID is 13014350. Please dial in
approximately 10 minutes prior to the start of the call. A telephone
replay will be available beginning approximately four hours after the
call through May 11, 2017, and may be accessed by dialing 855-859-2056
from the United States and Canada or 404-537-3406 internationally. The
replay passcode is 13014350.
To access the live and subsequently archived webcast of the conference
call, go to the Investor Relations section of the company’s website at ir.dexterasurgical.com.
Please connect to the website at least 15 minutes prior to the
presentation to allow for any necessary software downloads.
The webcast is also being distributed through the Thomson StreetEvents
Network. Institutional investors can access the call via Thomson
StreetEvents at www.streetevents.com,
a password-protected event management site.
About Dextera Surgical
Dextera Surgical (Nasdaq:DXTR) designs and manufactures proprietary
stapling devices for minimally invasive surgical procedures.
Dextera Surgical also markets automated anastomosis devices for coronary
artery bypass graft (CABG) surgery on the market today: the C-Port®
Distal Anastomosis Systems and PAS-Port® Proximal Anastomosis System.
These products are sold by Dextera Surgical under the Cardica brand name.
View source version on businesswire.com: http://www.businesswire.com/news/home/20170502006146/en/
Source: Dextera Surgical Inc.
Dextera Surgical Inc.
Bob Newell, 650-331-7133
Finance and Chief Financial Officer